Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-05

FDA Approved: LARIN 1.5/30 — Supplemental Application (Northstar Rx LLC)

View source ↗

Summary

The FDA approved a supplemental application for LARIN 1.5/30, a generic oral contraceptive containing norethindrone acetate and ethinyl estradiol, from Northsta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LARIN 1.5/30 (Norethindrone acetate/ethinyl estradiol)

Snippet

SUPPL AP for LARIN 1.5/30 (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL)